No Data
No Data
No Data
No Data
No Data
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (NYSE:SER), a
GlobeNewswireApr 18 04:05
Serina Therapeutics: Strategic Restructuring and Merger Success
TipRanksApr 2 05:42
News On AgeX Therapeutics Inc. (AGE) Now Under SER
News On AgeX Therapeutics Inc. (AGE) Now Under SER
Dow JonesMar 28 05:08
Serina Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 61.6%
Serina Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 61.6%
BenzingaMar 27 22:04
Serina Therapeutics Announces Completion of Merger With AgeX Therapeutics
Shares of Serina to commence trading on NYSE American under the ticker symbol "SER" on March 27, 2024Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024;
GlobeNewswireMar 27 05:04
AgeX Therapeutics GAAP EPS of -$13.73
Seeking AlphaMar 25 12:59
No Data
No Data